Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01881191 · ClinicalTrials.gov registry record
Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months
A clinical trial, sponsored by University at Buffalo.
- Completed
- Registry status
- 50
- Enrollment target
NCT01881191 is a clinical trial that has completed, run by University at Buffalo. The registered enrollment target is 50 participants.
The verdict
NCT01881191 has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study will evaluate the effects of Aubagio on changes in the brain using MRI.
Interventions
- OTHER MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01881191
The ClinicalTrials.gov registry entry for NCT01881191 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT01881191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01881191 about?
NCT01881191 is a clinical study titled "Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months". This study will evaluate the effects of Aubagio on changes in the brain using MRI.
What is the current status of trial NCT01881191?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-06. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01881191?
The interventions under investigation include: MRI (OTHER).
Who is sponsoring clinical trial NCT01881191?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.